Cantel Medical acquires ConFirm’s sterilization monitoring business CANTEL MEDICAL CORP prostate treatment . , through its Crosstex International subsidiary, has additional expanded its infection avoidance and control business by purchasing the sterilization monitoring business of ConFirm Monitoring Systems, Inc.0 million in GAAP sales, the privately-held business was founded a decade ago and conducts over two million tests each year.5 million in cash at closing and contingent consideration as high as an additional $1.through January 31 0 million based on achievement of specified sales levels, 2012.
Canyon Pharmaceuticals announces the availability of Iprivask inhibitor for prevention of DVT Canyon PharmaceuticalsTM , the first direct thrombin inhibitor approved in the usa by the Food and Medication Administration for preventing deep vein thrombosis , which might lead to pulmonary embolism in individuals undergoing elective hip alternative surgery. VTE, one of the most common complications in surgical sufferers, is connected with increased hospital costs, length of stay, morbidity, and mortality.’ Few alternatives can be found to heparin-centered anticoagulation for DVT prophylaxis in the hospitalized patient. VTE prophylaxis therapy with heparin-based anticoagulation could be complicated by a number of untoward events including thrombocytopenia, which has been shown to improve short-term mortality.